$7.62
0.7010.12%
At close: -
$6.95
-0.67-8.79%
After Hours: 9:27 AM EDT
Comments
Loading...
Gyre Therapeutics (GYRE) Forecast
NewsEarningsGyre Therapeutics (GYRE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Gyre Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:GYRE | Benzinga
Explore Gyre Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GYRE.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gyre Therapeutics (GYRE) stock?
You can purchase shares of Gyre Therapeutics (NASDAQ:GYRE) through any online brokerage.
Who are Gyre Therapeutics (GYRE) competitors?
Other companies in Gyre Therapeutics’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).
What is the forecast, or price target, for Gyre Therapeutics (GYRE) stock?
There is no analysis for Gyre Therapeutics to provide a consensus price target.
What is the current price for Gyre Therapeutics (GYRE)?
The stock price for Gyre Therapeutics (NASDAQ: GYRE) is $6.95 last updated April 7, 2025 at 9:27 AM EDT.
Does Gyre Therapeutics (GYRE) pay a dividend?
There are no upcoming dividends for Gyre Therapeutics.
When is Gyre Therapeutics (NASDAQ:GYRE) reporting earnings?
Gyre Therapeutics’s Q1 earnings are confirmed for Monday, May 19, 2025.
Is Gyre Therapeutics (GYRE) going to split?
There is no upcoming split for Gyre Therapeutics.
What sector and industry does Gyre Therapeutics (GYRE) operate in?
Gyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.